InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（5 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
5
T+90 胜率
100%
T+90 平均收益
+60.8%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Pande Atul, 董事. Insider active across 2 companies, notably Karuna Therapeutics, Inc.. In total, 28 disclosures have been recorded. Breakdown: 2 buys · 5 sells. Total volume traded: €584k. History available since 1 April 2021. The latest transaction was filed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Pande Atul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
1,500 股@ US$8.43Common StockSEC:0001764013-26-000103:0
1,500 股@ US$43.27Common StockSEC:0001764013-26-000103:1
1,500 股@ US$39.800.0007% mcap9.7% 占其流量Common StockSEC:0001643071-26-000007:1
1,500 股@ US$8.430.0002% mcap2.1% 占其流量Common StockSEC:0001643071-26-000007:0
1,500 股Common StockSEC:0001764013-26-000071:0
1,500 股Common StockSEC:0001764013-26-000071:1
13,880 股0Common StockSEC:0001764013-26-000046:0
16,188 股0Common StockSEC:0001764013-25-000047:0
7,750 股@ US$28.5441.1% 占其流量Common StockSEC:0001764013-24-000200:0
11,255 股0Common StockSEC:0001764013-24-000061:0
990 股@ US$330.0030.4% 占其流量Common StockSEC:0001140361-24-013932:0
4,129 股@ US$38.8028.8% 占其流量Common StockSEC:0001764013-23-000155:0
990 股0Common StockSEC:0000950170-23-029403:0
12,523 股0Common StockSEC:0001764013-23-000047:0
15,000 股@ US$5.6016.7% 占其流量Common StockSEC:0001764013-22-000126:0
标准退出：2022年12月29日 (T+90)
21,059 股0Common StockSEC:0001764013-22-000095:0
2,500 股@ US$16.005.5% 占其流量Common StockSEC:0001593968-22-000362:0
21,726 股0Common StockSEC:0001764013-22-000015:0
2,500 股@ US$16.005.5% 占其流量Common StockSEC:0001593968-22-000017:0
2,500 股@ US$16.005.5% 占其流量Common StockSEC:0001593968-21-002517:0
2,500 股@ US$16.005.4% 占其流量Common StockSEC:0001593968-21-002355:0
2,500 股@ US$16.005.4% 占其流量Common StockSEC:0001593968-21-002217:0
2,500 股@ US$16.005.3% 占其流量Common StockSEC:0001593968-21-002050:0
5,000 股@ US$7.986.3% 占其流量Common StockSEC:0001764013-21-000088:0
标准退出：2021年11月11日 (T+90)
2,500 股@ US$16.005.2% 占其流量Common StockSEC:0001593968-21-001919:0
28 条申报中的 25 条
About Pande Atul
Pande Atul is Administrateur of Immunovant, Inc. and Karuna Therapeutics, Inc. He has 24 filings in total. Among the recent filings we hold, they cover the period from 2021-05-03 to 2026-06-26, with buys of EUR 119454 and sells of EUR 657041, and the most common transaction nature is Levée d'options.
